Literature DB >> 2431058

Human T clones reactive to the sexual stages of Plasmodium falciparum malaria. High frequency of gamete-reactive T cells in peripheral blood from nonexposed donors.

M F Good, I A Quakyi, A Saul, J A Berzofsky, R Carter, L H Miller.   

Abstract

Malarial gametocytes, which are taken up by mosquitoes during a blood meal, develop in the gut of the mosquito into gametes. Gametes and gametocytes contain the target antigens of transmission-blocking immunity. Here, we show that the peripheral blood of nonexposed donors contains Plasmodium falciparum gamete-reactive T cells at frequencies ranging from 1/300 to 1/4000. Studies on long-term clones demonstrated that these cells often recognized antigens shared between gametes and asexual stage parasites or even between heterologous gametes, although it has been possible to derive a P. falciparum gamete-specific T clone. The T clones examined were T3+, T4+, T8-, and either HLA-DR- or HLA-DQ-restricted. They responded to gametes by both proliferation and the secretion of gamma-interferon. The gamete-specific clone and other asexual cross-reactive clones examined could be stimulated in vitro by a preparation of mature gametocytes within RBC, but not by RBC alone, suggesting that gametocytes are immunogenic or can become immunogenic for T cells in vivo. The significance of these observations to mosquito transmission of malaria and development and application of a gamete vaccine are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2431058

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Mapping of specific and promiscuous HLA-DR-restricted T-cell epitopes on the Plasmodium falciparum 27-kilodalton sexual stage-specific antigen.

Authors:  C E Contreras; I N Ploton; R F Siliciano; C L Karp; R Viscidi; N Kumar
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

2.  Long-term protection of squirrel monkeys (Saimiri sciureus) against Plasmodium falciparum challenge inoculations after various time intervals.

Authors:  C Roussilhon; T Fandeur; J P Dedet
Journal:  Parasitol Res       Date:  1988       Impact factor: 2.289

3.  Interactions of CD4+ and CD8+ human T lymphocytes from malaria-unprimed donors with Plasmodium falciparum schizont stage.

Authors:  C Roussilhon; M Agrapart; C Behr; P Dubois; J J Ballet
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

Review 4.  Status of malaria vaccine research.

Authors:  G A Targett
Journal:  J R Soc Med       Date:  1989       Impact factor: 5.344

5.  A whole parasite transmission-blocking vaccine for malaria: an ignored strategy.

Authors:  Michael F Good; Stephanie K Yanow
Journal:  Emerg Top Life Sci       Date:  2017-12-22

Review 6.  Immune Responses to the Sexual Stages of Plasmodium falciparum Parasites.

Authors:  Jonas A Kengne-Ouafo; Colin J Sutherland; Fred N Binka; Gordon A Awandare; Britta C Urban; Bismarck Dinko
Journal:  Front Immunol       Date:  2019-02-11       Impact factor: 7.561

Review 7.  Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites.

Authors:  Roos M de Jong; Surafel K Tebeje; Lisette Meerstein-Kessel; Fitsum G Tadesse; Matthijs M Jore; Will Stone; Teun Bousema
Journal:  Immunol Rev       Date:  2019-12-16       Impact factor: 12.988

Review 8.  The role of different components of the immune system against Plasmodium falciparum malaria: Possible contribution towards malaria vaccine development.

Authors:  Wilson L Mandala; Visopo Harawa; Fraction Dzinjalamala; Dumizulu Tembo
Journal:  Mol Biochem Parasitol       Date:  2021-10-16       Impact factor: 1.759

9.  Human adenovirus 5-vectored Plasmodium falciparum NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection.

Authors:  Cindy Tamminga; Martha Sedegah; Santina Maiolatesi; Charlotte Fedders; Sharina Reyes; Anatalio Reyes; Carlos Vasquez; Yolanda Alcorta; Ilin Chuang; Michele Spring; Michael Kavanaugh; Harini Ganeshan; Jun Huang; Maria Belmonte; Esteban Abot; Arnel Belmonte; Joglenna Banania; Fouzia Farooq; Jittawadee Murphy; Jack Komisar; Nancy O Richie; Jason Bennett; Keith Limbach; Noelle B Patterson; Joseph T Bruder; Meng Shi; Edward Miller; Sheetij Dutta; Carter Diggs; Lorraine A Soisson; Michael R Hollingdale; Judith E Epstein; Thomas L Richie
Journal:  Hum Vaccin Immunother       Date:  2013-06-04       Impact factor: 3.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.